GABAPENTIN
- Product NDC
- 68788-8176
- 11-digit product format
- 687888176
- Labeler code
- 68788
- Product ID
- 68788-8176_1e741495-a619-41e4-a466-0d2fb79df358
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA075360
- Marketing category
- ANDA
- Marketing start
- 2022-04-27
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68788-8176 | GABAPENTIN CAPSULE [PREFERRED PHARMACEUTICALS INC.] | 3 | Legacy NDC | 20240504_1e741495-a619-41e4-a466-0d2fb79df358.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-8176-1 | 68788817601 | 100 CAPSULE in 1 BOTTLE (68788-8176-1) | 100 capsule | 2022-04-27 | 0000-00-00 | No | No | Current |
| 68788-8176-3 | 68788817603 | 30 CAPSULE in 1 BOTTLE (68788-8176-3) | 30 capsule | 2022-04-27 | 0000-00-00 | No | No | Current |
| 68788-8176-6 | 68788817606 | 60 CAPSULE in 1 BOTTLE (68788-8176-6) | 60 capsule | 2022-04-27 | 0000-00-00 | No | No | Current |
| 68788-8176-8 | 68788817608 | 120 CAPSULE in 1 BOTTLE (68788-8176-8) | 120 capsule | 2022-04-27 | 0000-00-00 | No | No | Current |
| 68788-8176-9 | 68788817609 | 90 CAPSULE in 1 BOTTLE (68788-8176-9) | 90 capsule | 2022-04-27 | 0000-00-00 | No | No | Current |